NRX Pharmaceuticals Inc
NRXP
Get informed when a big investor buys or sells
+ FollowMarket Cap$57.39M
Close$
$0.57
81.3% downside
Current Fair Value
81.3% downsideOvervalued by 81.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $57.39 Million |
|---|---|
| Enterprise Value | $31.54 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.34 |
| Beta | 2.19 |
| Outstanding Shares | 37,649,382 |
Return
| Return on Equity | 13811.76% |
|---|---|
| Return on Assets | -68.74% |
| Return on Invested Capital | -7598.25% |
Valuation & Multiples
| P/E Ratio | -4.47 |
|---|---|
| PEG | 74.05 |
| Price to Sales | - |
| Price to Book Ratio | -3.03 |
| Enterprise Value to Revenue | 9.29 |
| Enterprise Value to EBIT | -1.45 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | -4.91 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$1.33 M
Average shareholder expectationNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-0.26
Average shareholder expectationRevenue Estimate
$1.33 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1691▼ 83.78% |
|---|---|
| Total Calls | 469,600▲ 257.11% |
| Total Puts | 79,400▼ 40.03% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 30.91%▲ 11.72% |
|---|---|
| Total Invested | $47.59M▲ 259.26% |
| Investors Holding | 52▲ 14.00% |
ESG Score
No data
About NRX Pharmaceuticals Inc
2 employeesBig Rock Partners is a blank check company formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more busi...